CA3010982A1 - Alpha chain of the high-affinity ige receptor (fceria) - Google Patents

Alpha chain of the high-affinity ige receptor (fceria) Download PDF

Info

Publication number
CA3010982A1
CA3010982A1 CA3010982A CA3010982A CA3010982A1 CA 3010982 A1 CA3010982 A1 CA 3010982A1 CA 3010982 A CA3010982 A CA 3010982A CA 3010982 A CA3010982 A CA 3010982A CA 3010982 A1 CA3010982 A1 CA 3010982A1
Authority
CA
Canada
Prior art keywords
fceria
alpha chain
ige receptor
affinity ige
alanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3010982A
Other languages
English (en)
French (fr)
Inventor
Oskar SMRZKA
Marwa MOSTAGEER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affiris AG
Original Assignee
Affiris AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affiris AG filed Critical Affiris AG
Publication of CA3010982A1 publication Critical patent/CA3010982A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CA3010982A 2016-01-13 2017-01-13 Alpha chain of the high-affinity ige receptor (fceria) Abandoned CA3010982A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16020009.3 2016-01-13
EP16020009.3A EP3192806A1 (en) 2016-01-13 2016-01-13 Alpha chain of the high-affinity ige receptor (fceria)
PCT/EP2017/050646 WO2017121842A1 (en) 2016-01-13 2017-01-13 Alpha chain of the high-affinity ige receptor (fceria)

Publications (1)

Publication Number Publication Date
CA3010982A1 true CA3010982A1 (en) 2017-07-20

Family

ID=55357837

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3010982A Abandoned CA3010982A1 (en) 2016-01-13 2017-01-13 Alpha chain of the high-affinity ige receptor (fceria)

Country Status (8)

Country Link
US (1) US20190127438A1 (cg-RX-API-DMAC10.html)
EP (2) EP3192806A1 (cg-RX-API-DMAC10.html)
JP (1) JP2019510737A (cg-RX-API-DMAC10.html)
CN (1) CN108473551A (cg-RX-API-DMAC10.html)
AU (1) AU2017207854A1 (cg-RX-API-DMAC10.html)
CA (1) CA3010982A1 (cg-RX-API-DMAC10.html)
RU (1) RU2018129024A (cg-RX-API-DMAC10.html)
WO (1) WO2017121842A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7780186B2 (ja) 2018-10-29 2025-12-04 コデクシス， インコーポレイテッド 操作されたｄｎａポリメラーゼバリアント
CN111100210B (zh) * 2019-01-30 2022-04-19 武汉九州钰民医药科技有限公司 一种Fc融合蛋白及其应用
EP3711772A1 (en) 2019-03-20 2020-09-23 Oslo Universitetssykehus HF Recombinant proteins and fusion proteins
MX2022000285A (es) 2019-07-08 2022-02-03 Gi Innovation Inc Dimero de polipeptido con alto contenido de acido sialico, que comprende el dominio extracelular de la subunidad alfa del receptor fc de ige y composicion farmaceutica que comprende el mismo.
CN110716054A (zh) * 2019-09-11 2020-01-21 天津医科大学 一种血清亲细胞性免疫球蛋白e的定量检测试剂盒
FR3108515B1 (fr) * 2020-03-26 2022-03-25 Ct Hospitalier Universitaire Toulouse Colonne d’aphérèse pour le traitement de la polyarthrite rhumatoïde
KR102468170B1 (ko) * 2020-07-17 2022-11-17 (주)지아이이노베이션 ＩｇＥ Ｆｃ 수용체 알파서브유닛의 세포외 도메인 및 항-IL-4R 항체를 포함하는 융합단백질 및 이의 용도
JP2026511640A (ja) * 2023-03-29 2026-04-14 グリフォルス・ワールドワイド・オペレーションズ・リミテッド ＦｃεＲＩβ自己抗体のレベルが低減された血漿製剤の組成物および調製方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4770774A (en) 1985-09-19 1988-09-13 Toray Industries, Inc. Column for removing β2 -microglobulin
US5985599A (en) 1986-05-29 1999-11-16 The Austin Research Institute FC receptor for immunoglobulin
US4962035A (en) 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
AU691297B2 (en) 1994-05-13 1998-05-14 Miltenyi Biotec Gmbh Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
IL116436A (en) * 1995-12-18 2006-12-31 Yissum Res Dev Co Fc?Á-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES AND
AR008077A1 (es) 1996-07-26 1999-12-09 Talarico Salinas Laura Beatriz Un polipeptido de fusion o una sal del mismo, su uso, un proceso para prepararlos, una composicion farmaceutica que los comprende, y un vector.
GB9715387D0 (en) 1997-07-23 1997-09-24 Gould Hannah J Immunoglobulin-binding polypeptides and their use
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
EP1006183A1 (en) 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant soluble Fc receptors
CA2385778A1 (en) * 1999-09-21 2001-03-29 Isis Innovation Limited Modulation of ige receptor cell surface expression
AU2001273456A1 (en) * 2000-07-13 2002-01-30 Hyseq, Inc. Soluble immunoglobulin e receptor alpha like molecules
US8354109B2 (en) 2005-12-13 2013-01-15 Suppremol Gmbh Multimeric Fc receptor polypeptides
WO2012140214A1 (en) 2011-04-13 2012-10-18 Biomay Ag IMMUNOAFFINITY SEPARATION MATERIALS COMPRISING ANTI-IgE ANTIBODY DERIVATIVES
CN102660569B (zh) 2012-04-21 2013-11-06 大连理工大学 一种重组人IgE受体蛋白的制备方法及应用

Also Published As

Publication number Publication date
WO2017121842A1 (en) 2017-07-20
US20190127438A1 (en) 2019-05-02
RU2018129024A (ru) 2020-02-13
EP3402813A1 (en) 2018-11-21
AU2017207854A1 (en) 2018-06-07
CN108473551A (zh) 2018-08-31
JP2019510737A (ja) 2019-04-18
EP3192806A1 (en) 2017-07-19
RU2018129024A3 (cg-RX-API-DMAC10.html) 2020-05-29

Similar Documents

Publication Publication Date Title
EP4446337A3 (en) Mutated glycoprotein of vesicular stomatitis virus
EA202090090A1 (ru) Включение неприродных нуклеотидов и способы с ними
CY1124019T1 (el) Σταθεροποιημενη διαλυτη πρωτεϊνη προσυντηξης rsv f για χρηση στην προφυλαξη απο λοιμωξη rsv
EA201792651A1 (ru) Аденовирусные полинуклеотиды и полипептиды
RU2016140627A (ru) Бета-лактамазы с улучшенными свойствами для лечения
WO2016071376A3 (en) Fc-region variants with modified fcrn-binding and methods of use
WO2016115168A8 (en) Incorporation of unnatural nucleotides and methods thereof
WO2016118014A3 (en) Anti-senescence compounds and uses thereof
NZ579566A (en) Modified fgf-21 polypeptides and their uses
TW200509899A (en) Amino acid composition and supplemental solution
WO2017075505A3 (en) Novel polypeptides with improved proteolytic stability, and methods of preparing and using same
MX2018000697A (es) Peptidos anti-inflamatorios y usos de los mismos.
MX2022007881A (es) Proteina f mutante del virus sincitial respiratorio (rsv) y usos de la misma.
EP4397374A3 (en) Improved peptide pharmaceuticals for insulin resistance
MX2017006748A (es) Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.
EP4374913A3 (en) Novel human serum albumin mutant
IL281316B (en) atf5 peptide variants and uses thereof
NZ736642A (en) Short synthetic peptide for treatment and/or prophylaxis of autoimmune and inflammatory disorders
BR112019002448A2 (pt) derivado de benzofenona, dispersão de copolímero aquosa, e, composição de revestimento aquosa.
CR20180008A (es) Variantes de il-37
ZA202103259B (en) Modified cas9 protein, and use thereof
WO2016094829A8 (en) Self-assembling peptides comprising non-ionic polar amino acids
EP3298908A3 (en) Protein-based amino acid composition for use prior to exercise
IN2015DN03883A (cg-RX-API-DMAC10.html)
ATE418877T1 (de) Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20220713